Burns & Levinson LLP represented Lowell Therapeutics, Inc. in its sale to AcelRx Pharmaceuticals. AcelRx Pharmaceuticals (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
